AbbVie has closed the acquisition of Pharmacyclics and confirms it will continue to outsource manufacture the oncology drug Imbruvica.
From new service offerings to manufacturing deals to more formal strategic partnerships, the world of contract research and manufacturing organizations has been busy as of late. Here’s a roundup of some of the deals and new offerings:
The fourth generation of enhancements to Parexel’s Randomization and Trial Supply Management (RTSM) service aims to simplify patient randomization and clinical supply management to reduce delivery timelines.
With the integration of Covance moving along steadily, Dave King, chairman and CEO of LabCorp, told investors last week at the UBS Healthcare Conference that LabCorp is ramping up a series of initiatives that will lead to $300m (€276m) in new revenue opportunities.
Lonza shipped a sample batch of a drug for resistant cancers this week and is set produce commercial supplies if it goes on to be approved says Sunshine Biopharma.
Merck Millipore has entered an agreement whereby it will control and manage the Singulex Life Science Research business, which offers a technology that can provide ultra-sensitive protein detection.